The impact of drugs against dementia on cognition in aging and mild cognitive impairment.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D003071:Cognition / Q000187:drug effects; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology; D003704:Dementia / Q000150:complications / Q000188:drug therapy*; D000077265:Donepezil; D005260:Female; D005702:Galantamine / Q000627:therapeutic use; D020441:Ginkgo biloba; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D016239:MEDLINE / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D018697:Nootropic Agents / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use; D010936:Plant Extracts / Q000627:therapeutic use; D000096983:Ginkgo Extract
D000077265:Donepezil; D005702:Galantamine; D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract